Behrad Derakhshan

Insider Reports History

Entity
Individual
Location
3415 Colorado Ave., Boulder, CO
Signature
/s/ John R Moore Attorney-in-Fact for Behrad Derakhshan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Behrad Derakhshan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Edgewise Therapeutics, Inc. Chief Business Officer Common Stock 16.8K $506K $30.03 Feb 5, 2025 Direct
Edgewise Therapeutics, Inc. Chief Business Officer Restricted Stock Units 23.1K $437K $18.91 Aug 12, 2024 Direct
Edgewise Therapeutics, Inc. Chief Business Officer Stock Option (Right to Buy) 92.9K Feb 5, 2025 Direct

Insider Reports Filed by Behrad Derakhshan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EWTX Edgewise Therapeutics, Inc. Feb 5, 2025 3 -$281K 4 Feb 7, 2025 Chief Business Officer
EWTX Edgewise Therapeutics, Inc. Sep 20, 2024 3 -$1.14M 4 Sep 24, 2024 Chief Business Officer
EWTX Edgewise Therapeutics, Inc. Aug 12, 2024 2 $0 4 Aug 14, 2024 Chief Business Officer
EWTX Edgewise Therapeutics, Inc. May 1, 2024 3 -$32.5K 4 May 3, 2024 Chief Business Officer
EWTX Edgewise Therapeutics, Inc. Feb 7, 2024 9 -$181K 4 Feb 9, 2024 Chief Business Officer
EWTX Edgewise Therapeutics, Inc. Aug 17, 2023 1 $0 4 Aug 18, 2023 Chief Business Officer
EWTX Edgewise Therapeutics, Inc. May 1, 2023 3 -$15.6K 4 May 3, 2023 Chief Business Officer
EWTX Edgewise Therapeutics, Inc. Aug 8, 2022 1 $0 4 Aug 10, 2022 Chief Business Officer
EWTX Edgewise Therapeutics, Inc. May 1, 2022 1 $0 4 May 3, 2022 Chief Business Officer
EWTX Edgewise Therapeutics, Inc. Aug 17, 2021 1 $0 4 Aug 19, 2021 Chief Business Officer